Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation

Behavioural Brain Research

Volumn 224, Issue 1, 2011, Pages 15-22

  Hasan, Alkomiet ^a   Nitsche, Michael A ^a   Rein, Bettina ^a   Schneider Axmann, Thomas ^a   Guse, Birgit ^a   Gruber, Oliver ^a   Falkai, Peter ^a   Wobrock, Thomas ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cortical plasticity; GABA; NMDA; Schizophrenia; Transcranial direct current stimulation; Transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; AMISULPRIDE; ARIPIPRAZOLE; BIPERIDEN; CHLORPROMAZINE; CITALOPRAM; DIAZEPAM; DOPAMINE RECEPTOR; ESCITALOPRAM; FLUPENTIXOL; LORAZEPAM; MIRTAZAPINE; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EVOKED MUSCLE RESPONSE; FACILITATION; FEMALE; GENDER; HANDEDNESS; HUMAN; LATENT INHIBITION; LATENT PERIOD; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; SYNAPTIC TRANSMISSION; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; LONG-TERM POTENTIATION; MALE; MIDDLE AGED; MOTOR CORTEX; REACTION TIME; SCHIZOPHRENIA, PARANOID; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79960247529     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.05.017     Document Type: Article

References (61)

1. Pascual-Leone A., Amedi A., Fregni F., Merabet L.B. The plastic human brain cortex. Annu Rev Neurosci 2005, 28:377-401.
2. Haracz J.L. Neural plasticity in schizophrenia. Schizophr Bull 1985, 11:191-229.
3. Bliss T.V., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973, 232:331-356.
4. Kolb B., Whishaw I.Q. Brain plasticity and behavior. Annu Rev Psychol 1998, 49:43-64.
5. Massey P.V., Bashir Z.I. Long-term depression: multiple forms and implications for brain function. Trends Neurosci 2007, 30:176-184.
6. Fitzgerald P.B., Brown T.L., Marston N.A., Oxley T., De Castella A., Daskalakis Z.J., et al. Reduced plastic brain responses in schizophrenia: a transcranial magnetic stimulation study. Schizophr Res 2004, 71:17-26.
7. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 2003, 97:153-179.
8. Paz R.D., Tardito S., Atzori M., Tseng K.Y. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol 2008, 18:773-786.
9. Eastwood S.L., Harrison P.J. Cellular basis of reduced cortical reelin expression in schizophrenia. Am J Psychiatry 2006, 163:540-542.
10. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 2010.
11. Paz R.D., Andreasen N.C., Daoud S.Z., Conley R., Roberts R., Bustillo J., et al. Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. Am J Psychiatry 2006, 163:1829-1831.
12. Frantseva M.V., Fitzgerald P.B., Chen R., Moller B., Daigle M., Daskalakis Z.J. Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex 2008, 18:990-996.
13. Daskalakis Z.J., Christensen B.K., Fitzgerald P.B., Chen R. Dysfunctional neural plasticity in patients with schizophrenia. Arch Gen Psychiatry 2008, 65:378-385.
14. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R.B., Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 2002, 59:347-354.
15. Wobrock T., Schneider-Axmann T., Retz W., Rosler M., Kadovic D., Falkai P., et al. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation. Pharmacopsychiatry 2009, 42:194-201.
16. Fitzgerald P.B., Brown T.L., Daskalakis Z.J., Kulkarni J. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia. Psychiatry Res 2002, 114:11-22.
17. Eichhammer P., Wiegand R., Kharraz A., Langguth B., Binder H., Hajak G. Cortical excitability in neuroleptic-naive first-episode schizophrenic patients. Schizophr Res 2004, 67:253-259.
18. Pascual-Leone A., Manoach D.S., Birnbaum R., Goff D.C. Motor cortical excitability in schizophrenia. Biol Psychiatry 2002, 52:24-31.
19. Brenner C.A., Kieffaber P.D., Clementz B.A., Johannesen J.K., Shekhar A., O'Donnell B.F., et al. Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient informationŽ. Schizophr Res 2009, 113:332-338.
20. Rolls E.T., Loh M., Deco G., Winterer G. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci 2008, 9:696-709.
21. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., Sanchez C.E., et al. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia. Am J Psychiatry 2004, 161:490-500.
22. Cahn W., Rais M., Stigter F.P., van Haren N.E., Caspers E., Hulshoff Pol H.E., et al. Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol 2009, 19:147-151.
23. Lieberman J.A. Is schizophrenia a neurodegenerative disorderŽ A clinical and neurobiological perspective. Biol Psychiatry 1999, 46:729-739.
24. Perez-Neri I., Ramirez-Bermudez J., Montes S., Rios C. Possible mechanisms of neurodegeneration in schizophrenia. Neurochem Res 2006, 31:1279-1294.
25. McGlashan T.H. Is active psychosis neurotoxicŽ. Schizophr Bull 2006, 32:609-613.
26. Fritsch B., Reis J., Martinowich K., Schambra H.M., Ji Y., Cohen L.G., et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 2010, 66:198-204.
27. Nitsche M.A., Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000, 527(Pt 3):633-639.
28. Nitsche M.A., Kuo M.F., Karrasch R., Wachter B., Liebetanz D., Paulus W. Serotonin affects transcranial direct current-induced neuroplasticity in humans. Biol Psychiatry 2009, 66:503-508.
29. Nitsche M.A., Jaussi W., Liebetanz D., Lang N., Tergau F., Paulus W. Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology 2004, 29:1573-1578.
30. Nitsche M.A., Fricke K., Henschke U., Schlitterlau A., Liebetanz D., Lang N., et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003, 553:293-301.
31. Liebetanz D., Nitsche M.A., Tergau F., Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 2002, 125:2238-2247.
32. Purpura D.P., McMurtry J.G. Intracellular activities and evoked potential changes during polarization of motor cortex. J Neurophysiol 1965, 28:166-185.
33. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
34. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
35. Guy W.B.R. CGI: clinical global impressions 1976, National Institute of Mental Health.
36. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 33:766-771.
37. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003, 64:663-667.
38. Wobrock T., Schneider M., Kadovic D., Schneider-Axmann T., Ecker U.K., Retz W., et al. Reduced cortical inhibition in first-episode schizophrenia. Schizophr Res 2008, 105:252-261.
39. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
40. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
41. Daskalakis Z.J., Christensen B.K., Chen R., Fitzgerald P.B., Zipursky R.B., Kapur S. Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation. Psychopharmacology (Berl) 2003, 170:255-262.
42. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res 2004, 154:1-10.
43. Malenka R.C. The long-term potential of LTP. Nat Rev Neurosci 2003, 4:923-926.
44. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384.
45. Heresco-Levy U. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:1113-1123.
46. Misonou H., Mohapatra D.P., Park E.W., Leung V., Zhen D., Misonou K., et al. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 2004, 7:711-718.
47. 2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man's land. J Physiol 2001, 532:285.
48. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995, 52:998-1007.
49. Ziemann U. TMS and drugs. Clin Neurophysiol Drugs 2004, 115:1717-1729.
50. Siebner H.R., Dressnandt J., Auer C., Conrad B. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998, 21:1209-1212.
51. Liu S.K., Fitzgerald P.B., Daigle M., Chen R., Daskalakis Z.J. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia. Biol Psychiatry 2009, 65:503-509.
52. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 2009, 35:549-562.
53. Manahan-Vaughan D., Kulla A. Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb Cortex 2003, 13:123-135.
54. Monte-Silva K., Kuo M.F., Thirugnanasambandam N., Liebetanz D., Paulus W., Nitsche M.A. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. J Neurosci 2009, 29:6124-6131.
55. Monte-Silva K., Liebetanz D., Grundey J., Paulus W., Nitsche M.A. Dosage-dependent non-linear effect of l-dopa on human motor cortex plasticity. J Physiol 2010, 588:3415-3424.
56. Nitsche M.A., Lampe C., Antal A., Liebetanz D., Lang N., Tergau F., et al. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Eur J Neurosci 2006, 23:1651-1657.
57. Konopaske G.T., Dorph-Petersen K.A., Pierri J.N., Wu Q., Sampson A.R., Lewis D.A. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 2007, 32:1216-1223.
58. Dazzan P., Morgan K.D., Orr K., Hutchinson G., Chitnis X., Suckling J., et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 2005, 30:765-774.
59. Lieberman J.A., Tollefson G.D., Charles C., Zipursky R., Sharma T., Kahn R.S., et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005, 62:361-370.
60. Kuo M.F., Paulus W., Nitsche M.A. Sex differences in cortical neuroplasticity in humans. Neuroreport 2006, 17:1703-1707.
61. Thirugnanasambandam N., Grundey J., Adam K., Drees A., Skwirba A.C., Lang N., et al. Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology 2010.